Pancreatic Cancer Symposium 2024
The Allegheny Health Network Cancer Institue is pleased to offer this exciting educational opportunity for Practicing Oncologists, Gastroenterologists, Primary Care Physicians, Radiation Oncologists, Registered Nurses, Surgeons, Advanced Practice Providers, and Radiologists to stay up to date with the latest advances in pancreatic cancer diagnosis, treatment, and research. Pancreatic cancer patients and their loved ones interested in the latest information and treatments are also welcome to attend.
Target Audience
Practicing oncologists, gastroenterologists, primary care physicians, radiation oncologists, registered nurses, surgeons, advanced practice providers, and radiologists can keep up with the latest advances in pancreatic cancer diagnosis, treatment, and research. Pancreatic cancer patients and their loved ones interested in the latest information and treatments are also welcome to attend.
Learning Objectives
1. Discuss Innovations in endoscopic and surgical management of pancreas cancer.
2. Discuss novel treatments and available clinical trials.
3. Develop networking collaborations for pancreas cancer.
4. Discuss sequencing therapies in metastatic PNET.
Accreditation:
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Allegheny General Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.